Analystreport

Dyne Therapeutics, Inc. (NASDAQ: DYN) is now covered by analysts at Jonestrading. They set a "buy" rating on the stock.

Dyne Therapeutics, Inc.  (DYN) 
Last dyne therapeutics, inc. earnings: 11/1 04:30 pm Check Earnings Report
US:NYSE Investor Relations: dynegy.com/investors/presentations-events